Rekah Pharmaceutical Industry Ltd. reported earnings results for the full year ended December 31, 2021. For the full year, the company reported sales was ILS 263.95 million compared to ILS 265.47 million a year ago. Net income was ILS 6.62 million compared to ILS 10.8 million a year ago.

Basic earnings per share from continuing operations was ILS 0.58 compared to ILS 0.95 a year ago. Basic earnings per share was ILS 0.58 compared to ILS 0.95 a year ago. Diluted earnings per share was ILS 0.58.